Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN NOS Cause Off label use? 75 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Off label use have been filed in association with BOTULINUM TOXIN NOS. This represents 27.6% of all adverse event reports for BOTULINUM TOXIN NOS.

75
Reports of Off label use with BOTULINUM TOXIN NOS
27.6%
of all BOTULINUM TOXIN NOS reports
11
Deaths
24
Hospitalizations

How Dangerous Is Off label use From BOTULINUM TOXIN NOS?

Of the 75 reports, 11 (14.7%) resulted in death, 24 (32.0%) required hospitalization, and 10 (13.3%) were considered life-threatening.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN NOS. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does BOTULINUM TOXIN NOS Cause?

Drug ineffective (99) Product use in unapproved indication (44) Migraine (40) Treatment failure (39) Headache (33) Nausea (32) Sedation (29) Drug intolerance (28) Pain (26) Fatigue (23)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which BOTULINUM TOXIN NOS Alternatives Have Lower Off label use Risk?

BOTULINUM TOXIN NOS vs BOTULINUM TOXIN TYPE A BOTULINUM TOXIN NOS vs BREMELANOTIDE BOTULINUM TOXIN NOS vs BRENTUXIMAB BOTULINUM TOXIN NOS vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN NOS vs BREO ELLIPTA

Related Pages

BOTULINUM TOXIN NOS Full Profile All Off label use Reports All Drugs Causing Off label use BOTULINUM TOXIN NOS Demographics